close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar8008Point95
Implied share price

Buy Undervalued by 43736.6%

5% margin of safety What's this?

EV / Revenue
Use Average
PLX
Protalix BioTherapeutics Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
WPI
Watson Pharmaceuticals, Inc.
Change
AMGN
Amgen, Inc.
Change
21754.88 48.12 27840.41 3.07 9.63 4.99
All amounts in millions
from last financial year
         
Implied Share Price $8008.95 $48816.26 $490050.91 $720973.31 $625005.38
Market Cap 1,701 1,229,412 125,743 110,264 107,989
Net Debt -52 20 -26,208 15,514 174
Enterprise Value (EV) 1,656 1,229,432 100,217 125,778 108,116
Revenue 34 44 32,639 13,062 21,662
Balance Sheet          
Total Assets 78 58 51,839 52,758 71,576
Total Liabilities 82 56 32,724 24,426 43,493
Shareholders Equity -3 2 19,115 28,331 28,083.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.